Showing results (211-220 of 504) with videos related to
Sort By:
Pageof 51
Hypertension (Dallas, Tex. : 1979)|July 15, 2009
Blood pressure is a major risk factor for renal death: an analysis of 560 352 participants from the Asia-Pacific regionConall M O'Seaghdha, Vlado Perkovic, Tai Hing Lam, et al.Diabetes Care|September 22, 2022
Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVASAkihiko Koshino, Meir Schechter, Taha Sen, et al.Canadian Family Physician Medecin De Famille Canadien|October 1, 2004
Inhaler therapy. What it means for children with asthmaKaren Parsons, Graham Worrall, John Knight, et al.Diabetologia|July 15, 2019
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON studyMegumi Oshima, Min Jun, Toshiaki Ohkuma, et al.Journal of the American Society of Nephrology : JASN|October 24, 2023
Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease ProgressionHiddo J L Heerspink, Niels Jongs, Patrick Schloemer, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 2, 2012
Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysisSuetonia C Palmer, Lucia Di Micco, Mona Razavian, et al.Nephrology (Carlton, Vic.)|February 10, 2018
Effect of extended hours dialysis on sleep quality in a randomized trialJin-Lan Liao, Oliver van den Broek-Best, Brendan Smyth, et al.Kidney International|April 29, 2023
Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trialsHiddo J L Heerspink, Niels Jongs, Brendon L Neuen, et al.Diabetes, Obesity & Metabolism|May 22, 2020
The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trialClare Arnott, Yuli Huang, Brendon L Neuen, et al.Diabetes, Obesity & Metabolism|February 19, 2021
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trialMin Jun, Katie Harris, Hiddo J L Heerspink, et al.Pageof 51